Immune profiling of plasma-derived extracellular vesicles identifies Parkinson disease.

Aged Aged, 80 and over Antigens, Surface Biomarkers / blood Case-Control Studies Cross-Sectional Studies Extracellular Vesicles / immunology Female Flow Cytometry Humans Male Middle Aged Multiple System Atrophy / blood Parkinson Disease / blood Parkinsonian Disorders / blood Protein Interaction Maps Sensitivity and Specificity Supervised Machine Learning Tauopathies / blood

Journal

Neurology(R) neuroimmunology & neuroinflammation
ISSN: 2332-7812
Titre abrégé: Neurol Neuroimmunol Neuroinflamm
Pays: United States
ID NLM: 101636388

Informations de publication

Date de publication:
11 2020
Historique:
received: 16 12 2019
accepted: 28 05 2020
entrez: 21 8 2020
pubmed: 21 8 2020
medline: 5 10 2021
Statut: epublish

Résumé

To develop a diagnostic model based on plasma-derived extracellular vesicle (EV) subpopulations in Parkinson disease (PD) and atypical parkinsonism (AP), we applied an innovative flow cytometric multiplex bead-based platform. Plasma-derived EVs were isolated from PD, matched healthy controls, multiple system atrophy (MSA), and AP with tauopathies (AP-Tau). The expression levels of 37 EV surface markers were measured by flow cytometry and correlated with clinical scales. A diagnostic model based on EV surface markers expression was built via supervised machine learning algorithms and validated in an external cohort. Distinctive pools of EV surface markers related to inflammatory and immune cells stratified patients according to the clinical diagnosis. PD and MSA displayed a greater pool of overexpressed immune markers, suggesting a different immune dysregulation in PD and MSA vs AP-Tau. The receiver operating characteristic curve analysis of a compound EV marker showed optimal diagnostic performance for PD (area under the curve [AUC] 0.908; sensitivity 96.3%, specificity 78.9%) and MSA (AUC 0.974; sensitivity 100%, specificity 94.7%) and good accuracy for AP-Tau (AUC 0.718; sensitivity 77.8%, specificity 89.5%). A diagnostic model based on EV marker expression correctly classified 88.9% of patients with reliable diagnostic performance after internal and external validations. Immune profiling of plasmatic EVs represents a crucial step toward the identification of biomarkers of disease for PD and AP.

Identifiants

DOI: 10.1212/NXI.0000000000000866 PMID: 32817412 PMC: PMC7428368
pubmed: 32817412
pii: 7/6/e866
doi: 10.1212/NXI.0000000000000866
pmc: PMC7428368
pii:
doi:

Substances chimiques

Antigens, Surface 0
Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Références

Int J Mol Sci. 2016 Feb 02;17(2):
pubmed: 26848654
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Neurology. 2003 Sep 9;61(5):686-9
pubmed: 12963764
Front Immunol. 2016 Jul 26;7:282
pubmed: 27507971
J Extracell Vesicles. 2016 Feb 19;5:29975
pubmed: 26901056
Immunol Rev. 2009 May;229(1):152-72
pubmed: 19426221
Mov Disord. 2006 Jan;21(1):89-93
pubmed: 16108021
J Allergy Clin Immunol. 2019 Sep;144(3):825-838
pubmed: 30926529
Mov Disord. 2012 Sep 15;27(11):1364-9
pubmed: 22927213
N Engl J Med. 2018 Sep 06;379(10):958-966
pubmed: 30184457
Neurobiol Dis. 2006 Feb;21(2):404-12
pubmed: 16182554
Ann Surg. 2019 Jan 18;:
pubmed: 30672800
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Eur J Neurosci. 2019 Feb;49(3):364-383
pubmed: 30474172
Front Pharmacol. 2012 Feb 17;3:15
pubmed: 22363285
Nat Rev Immunol. 2002 Aug;2(8):569-79
pubmed: 12154376
Proc Natl Acad Sci U S A. 2015 Apr 14;112(15):E1926-35
pubmed: 25825709
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
Brain Behav Immun. 2017 Feb;60:188-197
pubmed: 27751869
J Parkinsons Dis. 2018;8(3):385-398
pubmed: 29991141
Sci Rep. 2018 Sep 5;8(1):13276
pubmed: 30185816
Arch Neurol. 2011 Aug;68(8):1037-9
pubmed: 21825240
Neuroendocrinology. 2018;107(2):181-195
pubmed: 29439247
Cell Death Discov. 2017 Mar 06;3:17005
pubmed: 28280601
Neurology. 2013 Jan 29;80(5):496-503
pubmed: 23359374
Mol Med Rep. 2018 Mar;17(3):3775-3782
pubmed: 29257331
Parkinsonism Relat Disord. 2019 Apr;61:82-87
pubmed: 30502924
Lancet Neurol. 2006 Jan;5(1):75-86
pubmed: 16361025
Biochim Biophys Acta Gen Subj. 2017 May;1861(5 Pt A):1190-1199
pubmed: 28286014
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Neurology. 2015 Jul 7;85(1):40-7
pubmed: 26062630
Neuron. 2018 Dec 19;100(6):1337-1353.e5
pubmed: 30415998
Mol Cell Neurosci. 2006 Apr;31(4):642-8
pubmed: 16446100
Nature. 2017 Jun 29;546(7660):656-661
pubmed: 28636593
J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
pubmed: 1564476
Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):E7622-E7631
pubmed: 28827364
J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):720-729
pubmed: 32273329
Brain Behav Immun. 2018 Mar;69:591-602
pubmed: 29458199
Mov Disord. 2004 Oct;19(10):1221-6
pubmed: 15390000
Ann Clin Transl Neurol. 2015 Apr;2(4):353-61
pubmed: 25909081
Front Aging Neurosci. 2019 Jan 14;10:438
pubmed: 30692923
F1000Res. 2014 Jul 01;3:139
pubmed: 26594322
Nanomedicine. 2011 Dec;7(6):780-8
pubmed: 21601655
J Parkinsons Dis. 2017;7(4):569-576
pubmed: 28922170
J Autoimmun. 2012 May;38(2-3):J144-55
pubmed: 22119415
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
J Steroid Biochem Mol Biol. 2019 May;189:274-282
pubmed: 30654107
EURASIP J Bioinform Syst Biol. 2017 Dec;2017(1):6
pubmed: 28477207
F1000Res. 2015 Aug 5;4:484
pubmed: 27781081

Auteurs

Elena Vacchi (E)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Jacopo Burrello (J)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Dario Di Silvestre (D)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Alessio Burrello (A)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Sara Bolis (S)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Pierluigi Mauri (P)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Giuseppe Vassalli (G)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Carlo W Cereda (CW)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Cinthia Farina (C)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Lucio Barile (L)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
ORCID: 0000-0002-5827-0439

Alain Kaelin-Lang (A)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy.
ORCID: 0000-0002-5249-073X

Giorgia Melli (G)

From the Laboratory for Biomedical Neurosciences (E.V., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale; Faculty of Biomedical Sciences (E.V., G.V., L.B., A.K.-L., G.M.), Università della Svizzera Italiana; Cellular and Molecular Cardiology Laboratory (J.B., G.V.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Proteomic and Metabolomic Laboratory (D.D.S., P.M.), Institute for Biomedical Technologies-National Research Council (ITB-CNR), Segrate (Milan), Italy; Department of Electrical (A.B.), Electronic and Information Engineering "Guglielmo Marconi" (DEI), University of Bologna, Italy; Laboratory for Cardiovascular Theranostics (S.B., L.B.), Cardiocentro Ticino Foundation, Lugano, Switzerland; Neurology Department (C.W.C., A.K.-L., G.M.), Neurocenter of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano; and Immunobiology of Neurological Disorders Lab (C.F.), Institute of Experimental Neurology (INSpe) and Division of Neuroscience, IRCCS San Raffaele Scientific Institute, Milan, Italy. giorgia.melli@eoc.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Immune profiling of plasma-derived...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › Immune profiling of plasma-derived...
questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes de surface › Immune profiling of plasma-derived...
questionsmedicales.fr › Facteurs biologiques › Marqueurs biologiques › Immune profiling of plasma-derived...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études cas-témoins › Immune profiling of plasma-derived...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études transversales › Immune profiling of plasma-derived...
questionsmedicales.fr › Cellules › Structures cellulaires › Espace extracellulaire › Vésicules extracellulaires › Immune profiling of plasma-derived...
questionsmedicales.fr › Techniques d'investigation › Techniques cytologiques › Cytophotométrie › Cytométrie en flux › Immune profiling of plasma-derived...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Immune profiling of plasma-derived...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Immune profiling of plasma-derived...
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Atrophie multisystématisée › Immune profiling of plasma-derived...
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Maladie de Parkinson › Immune profiling of plasma-derived...
questionsmedicales.fr › Maladies du système nerveux › Maladies du système nerveux central › Troubles de la motricité › Syndromes parkinsoniens › Immune profiling of plasma-derived...
questionsmedicales.fr › Métabolisme › Voies et réseaux métaboliques › Cartes d'interactions protéiques › Immune profiling of plasma-derived...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Sensibilité et spécificité › Immune profiling of plasma-derived...
questionsmedicales.fr › Sciences de l'information › Méthodologies informatiques › Algorithmes › Intelligence artificielle › Apprentissage machine › Apprentissage machine supervisé › Immune profiling of plasma-derived...
questionsmedicales.fr › Maladies du système nerveux › Maladies neurodégénératives › Tauopathies › Immune profiling of plasma-derived...